Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Potential anticancer activities of chloroform subfraction from Peronema leaf on colon cancer HT-29 cells in vitro

Arsyik Ibrahim, Siswandono Siswandono, Bambang Prajogo Eko Wardojo.




Abstract
Cited by 3 Articles

A study on the cytotoxic activity of Sungkai (Peronema canescens Jack) used in vitro cell lines has not been reported. Peronema canescens leaves contain many secondary metabolites with potential cytotoxic activity. In vitro cell lines assay can be used to determine natural products’ anticancer activity. This study aimed to identify secondary metabolites of P. canescens leaf chloroform fraction and subfraction and to determine the effect of cytotoxicity (IC50) on HT-29 colon cancer cells. In this study, the cytotoxicity activities on HT-29 cells were evaluated by 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide assay using concentration ranges from 1.563 to 200.00 μg/ml. The detected secondary metabolites in the chloroform were alkaloids, terpenoids, steroids, flavonoids, and phenolics. The value of cytotoxic activity (IC50) against HT-29 colon cancer cells ranged from 14.807 to 34.448 μg/ml. The tests carried out showed that chloroform subfraction 3 showed potential cytotoxic activity in human HT-29 cancer cells with an IC50 value of 14.807 μg/ml and provided promising hope for further cytotoxicity studies.

Key words: Cytotoxicity, HT-29 cells, In vitro cell lines assay, Peronema canescens Jack, Secondary metabolites






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.